Financhill
Back

Merck & Quote, Financials, Valuation and Earnings

This Cash Calendar Could Help Ease the Bite of Inflation

Sign up here to claim yours.
Sell
35

MRK
Merck &

Last Price:
101.65
Seasonality Move:
2.47%

7 Day Trial

ALL ACCESS PASS

$ 7

2 minutes a day. 4x a week.

Here's how

Merck & Price Quote

$101.65
+0.01 (+-1.43%)
(Updated: November 30, 2024 at 5:48 AM ET)

Merck & Key Stats

Sell
35
Merck & (MRK) is a Sell

Day range:
$101.53 - $103.04
52-week range:
$94.48 - $134.63
Dividend yield:
3.03%
P/E ratio:
726.00
P/S ratio:
4.09
P/B ratio:
5.78%

Volume:
6.1M
Avg. volume:
11.5M
1-year change:
0.5%
Market cap:
$257.1B
Revenue:
$60.1B
EPS:
$4.77

How Much Does Merck & Make?

  • How Much Are Merck &'s Sales Annually?
    MRK Revenues are $60.1B
  • How Much Profit Does Merck &'s Make A Year?
    MRK net income is $365M

Is Merck & Growing As A Company?

  • What Is Merck &'s Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Merck &'s EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.33%

Merck & Stock Price Performance

  • Did Merck & Stock Go Up Last Month?
    Merck & share price went down by -2.01% last month
  • Did MRK's Share Price Rise Over The Last Year?
    MRK share price rose by 0.5% over the past 1 year

What Is Merck & 52-Week High & Low?

  • What Is Merck &’s 52-Week High Share Price?
    Merck & has traded as high as $134.63 over the past 52 weeks
  • What Is Merck &’s 52-Week Low Share Price?
    Merck & has traded as low as $94.48 over the past 52 weeks

Merck & Price To Free Cash Flow

  • Is Merck & Stock Overvalued?
    Merck & is trading at a price to free cash flow ratio of 17.41
  • Is Merck & Stock Undervalued?
    Merck & EV to Free Cash Flow ratio is 18.92
  • What Is Merck &’s Price Earnings Growth Ratio?
    MRK PEG ratio is 0.13
  • Is Merck & Trading At A Premium To Earnings?
    Merck & EV to EBIT ratio is 18.75

Is It Risky To Buy Merck &?

  • How Much Debt Does Merck & Have?
    Total long term debt quarterly is $38.1B
  • How Much Cash Does Merck & Have?
    Cash and short term investments quarterly total is $14.6B
  • What Is Merck &’s Book Value Per Share?
    Book value per share is 17.58

Is Merck & Cash Flow Positive?

  • What Is MRK Cash Flow From Operations?
    Cash flow from operations (TTM) is $18.3B
  • What Is Merck &’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.3B
  • What Is Merck &’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.2B

Merck & Return On Invested Capital

  • Is Management Doing A Good Job?
    MRK return on invested capital is 15.67%
  • What Is Merck & Return On Assets?
    ROA measures how assets are converting to revenues and is 11.06%
  • What Is MRK Return On Equity?
    ROE is a measure of profitability and is 29.26%

Merck & Earnings Date & Stock Price

  • What Is Merck &'s Stock Price Today?
    A single share of MRK can be purchased today for 101.64
  • What Is Merck &’s Stock Symbol?
    Merck & trades on the S&P500 under the ticker symbol: MRK
  • When Is Merck &’s Next Earnings Date?
    The next quarterly earnings date for Merck & is scheduled on January 31, 2025
  • When Is MRK's next ex-dividend date?
    Merck &'s next ex-dividend date is December 16, 2024
  • How To Buy Merck & Stock?
    You can buy Merck & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Merck & Competitors

  • Who Are Merck &'s Competitors?
    Below is a list of companies who compete with Merck & or are related in some way:
    • Amgen Inc (AMGN)
    • Johnson & Johnson (JNJ)
    • Eli Lilly and Co (LLY)
    • Moderna Inc (MRNA)
    • Pfizer Inc (PFE)

Merck & Dividend Yield

  • What Is MRK Dividend Yield?
    Merck &’s dividend yield currently is 3.03%
  • What Is Merck &’s Payout Ratio?
    Merck &’s payout ratio is 63.72%
  • When Did Merck & Last Pay A Dividend?
    The latest dividend pay date is December 1, 2024
  • What Is Merck &’s Dividend Per Share?
    Merck & pays a dividend of $0.77 per share

Merck & Analyst Estimates

YoY Growth Past Surprise
EPS: -33.33% 0.03%
Revenue: 4.35% 0.87%

Analyst Recommendations

Buy Recommendations: 15
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 130.89
Upside from Last Price: 28.78%

Major Shareholders

  • How many MRK shares are owned by institutional investors?
    3.1B MRK shares are owned by institutional investors
  • How many MRK shares are owned by insiders?
    3.8M MRK shares are owned by insiders